Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HL2351 in Patients With Cryopyrin Associated Periodic Syndromes
NCT02853084Phase 2Terminated
- Sponsor
- Handok
- Start
- Oct 2015
- Primary completion
- May 2017
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of hl2351 in Cryopyrin-associated periodic syndromes (CAPS), sponsored by Handok. Started Oct 2015; status: terminated.
02
Drugs
hl2351
03
Conditions
Cryopyrin-associated periodic syndromes (CAPS)
Beyond the preview
Go deeper on NCT02853084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02853084.